<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="EN" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Clin Pharmacol</journal-id><journal-id journal-id-type="pmc-domain-id">279</journal-id><journal-id journal-id-type="pmc-domain">brjclinpharm</journal-id><journal-id journal-id-type="publisher-id">bcp</journal-id><journal-title-group><journal-title>British Journal of Clinical Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0306-5251</issn><issn pub-type="epub">1365-2125</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC2015016</article-id><article-id pub-id-type="pmcid-ver">PMC2015016.1</article-id><article-id pub-id-type="pmcaid">2015016</article-id><article-id pub-id-type="pmcaiid">2015016</article-id><article-id pub-id-type="pmid">11136292</article-id><article-id pub-id-type="doi">10.1046/j.1365-2125.2000.00288.x</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Population Pharmacokinetics</subject></subj-group></article-categories><title-group><article-title>Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Sam</surname><given-names initials="WJ">W J</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Aw</surname><given-names initials="M">M</given-names></name><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Quak</surname><given-names initials="SH">S H</given-names></name><xref ref-type="aff" rid="au3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lim</surname><given-names initials="SM">S M</given-names></name><xref ref-type="aff" rid="au4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Charles</surname><given-names initials="BG">B G</given-names></name><xref ref-type="aff" rid="au5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chan</surname><given-names initials="SY">S Y</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ho</surname><given-names initials="PC">P C</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><aff id="au1"><label>1</label><institution>Department of Pharmacy, National University of Singapore</institution><addr-line>Singapore 119260</addr-line></aff><aff id="au2"><label>2</label><institution>Department of Paediatrics, National University Hospital</institution><addr-line>Singapore 119074</addr-line></aff><aff id="au3"><label>3</label><institution>Department of Paediatrics, National University of Singapore</institution><addr-line>Singapore 119260</addr-line></aff><aff id="au4"><label>4</label><institution>Department of Pharmacy, National University Hospital</institution><addr-line>Singapore 119074</addr-line></aff><aff id="au5"><label>5</label><institution>School of Pharmacy and Australian Centre for Paediatric Pharmacokinetics, The University of Queensland</institution><addr-line>Brisbane, Queensland, Australia 4067</addr-line></aff></contrib-group><author-notes><corresp id="cor1"><italic>Correspondence:</italic> Dr Paul C. Ho, Department of Pharmacy, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119260. Tel.: (65) 874 2651; Fax: (65) 779 1554; E-mail: <email>phahocl@nus.edu.sg</email></corresp></author-notes><pub-date pub-type="ppub"><month>12</month><year>2000</year></pub-date><volume>50</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">151583</issue-id><fpage>531</fpage><lpage>541</lpage><history><date date-type="received"><day>22</day><month>2</month><year>2000</year></date><date date-type="accepted"><day>22</day><month>8</month><year>2000</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>06</month><year>2001</year></date></event><event event-type="pmc-live"><date><day>14</day><month>01</month><year>2008</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-03-16 02:25:14.873"><day>16</day><month>03</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2000 Blackwell Science Ltd</copyright-statement><copyright-year>2000</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="bcp0050-0531.pdf"/><abstract><sec><title>Aims</title><p>The purpose of this study was to describe the population pharmacokinetics of intravenous and oral tacrolimus (FK506) in 20 Asian paediatric patients, aged 1&#8211;14 years, following liver transplantation and to identify possible relationships between clinical covariates and population parameter estimates.</p></sec><sec sec-type="methods"><title>Methods</title><p>Details of drug dosage histories, sampling times and concentrations were collected retrospectively from routine therapeutic drug monitoring data accumulated for at least 4 days after surgery. Before analysis, patients were randomly allocated to either the population data set (<italic>n</italic> = 16) or a validation data set (<italic>n</italic> = 4). The population data set was comprised of 771 concentration measurements of patients admitted over the last 3 years. Population modelling using the nonlinear mixed-effects model (NONMEM) program was performed on the population data set, using a one-compartment model with first-order absorption and elimination. Population average parameter estimates of clearance (CL), volume of distribution (<italic>V</italic>) and oral bioavailability (<italic>F</italic>) were sought; a number of clinical and demographic variables were tested for their influence on these parameters.</p></sec><sec><title>Results</title><p>The final optimal population models related clearance to age, volume of distribution to body surface area and bioavailability to body weight and total bilirubin concentration. Predictive performance of this model evaluated using the validation data set, which comprised 86 concentrations, showed insignificant bias between observed and model-predicted blood tacrolimus concentrations. A final analysis performed in all 20 patients identified the following relationships: CL (l h<sup>&#8722;1</sup>) = 1.46 *[1 + 0.339 * (AGE (years) &#8722;2.25)]; <italic>V</italic> (l) = 39.1 *[1 + 4.57 * (BSA (m<sup>2</sup>)&#8722;0.49)]; <italic>F</italic> = 0.197 *[1 + 0.0887 * (WT (kg) &#8722;11.4)] and <italic>F</italic> = 0.197 *[1 + 0.0887 * (WT (kg) &#8722;11.4)]*[1.61], if the total bilirubin &#8805; 200 &#181;mol l<sup>&#8722;1</sup>. The interpatient variabilities (CV%) in CL, <italic>V</italic> and <italic>F</italic> were 33.5%, 33.0% and 24.1%, respectively. The intrapatient variability (s.d.) among observed and model-predicted blood concentrations was 5.79 ng ml<sup>&#8722;1</sup>.</p></sec><sec><title>Conclusions</title><p>In this study, the estimates of the pharmacokinetic parameters of tacrolimus agreed with those obtained from conventional pharmacokinetic studies. It also identified significant relationships in Asian paediatric liver transplant patients between the pharmacokinetics of tacrolimus and developmental characteristics of the patients.</p></sec></abstract><kwd-group><kwd>FK506</kwd><kwd>liver transplantation</kwd><kwd>NONMEM</kwd><kwd>paediatrics</kwd><kwd>population pharmacokinetics</kwd><kwd>tacrolimus</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>